MGP and ovarian cancer: In this study, we performed detailed expression analysis of MGP at mRNA and protein levels in sensitive (A2780) and resistant to paclitaxel (A2780PR1) and topotecan (A2780TR1 and A2780TR2) ovarian cancer cell lines and their corresponding media.